Skip to content

-

-

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1080224515
Enrollment
236
Registered
2019-01-11
Start date
2018-11-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

investigational material(s) Generic name etc : - INN of investigational material : insulin degludec and insulin aspart Therapeutic category code : 249 Other hormone preparations (including antihormon

Sponsors

Novo Nordisk Pharma Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
efficacy -

Secondary

MeasureTime frame
safety efficacy -

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026